Hepatocellular neoplasms induced by low-number pancreatic islet transplants in autoimmune diabetic BB/Pfd rats

Cancer Research

Volumn 66, Issue 3, 2006, Pages 1833-1843

  Dombrowski, Frank ^a   Mathieu, Chantal ^b   Evert, Matthias ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE; GLYCOGEN; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; RAF PROTEIN; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; IMMUNOHISTOCHEMISTRY; ISLETS OF LANGERHANS TRANSPLANTATION; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; RATS; RATS, INBRED BB;

EID: 32944473299     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-2787     Document Type: Article

References (51)

1. Ricordi C, Strom TB. Clinical islet transplantation: advances and immunological challenges. Nat Rev Immunol 2004;4:259-68.
2. Rother KI, Harlan DM. Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus. J Clin Invest 2004;114:877-83.
3. Ryan EA, Lakey JRT, Paty BW, et al. Successful islet transplantation. Continued insulin reserve provides long-term glycemic control. Diabetes 2002;51:2148-57.
4. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000;343:230-8.
5. Ryan ER, Lakey JRT, Rajotte RV, et aL Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001;50:710-9.
6. Eckhard M, Lommel D, Hackstein N, et al. Disseminated periportal fatty degeneration after allogeneic intraportal islet transplantation in a patient with type 1 diabetes mellitus: a case report. Transplant Proc 2004;6:1111-6.
7. Bhargava R, Senior PA, Ackerman TE, et al. Prevalence of hepatic steatosis after islet transplantation and its relation to graft function. Diabetes 2004;53:1311-7.
8. Sever CE, Demetris AJ, Zeng Y, et al. Islet cell allotransplantation in diabetic patients. Histologic findings in four adults simultaneously receiving kidney or liver transplants. Am J Pathol 1992;140:1255-60.
9. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004;126:460-8.
10. El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004;127:827-34.
11. Caldwell SH, Crespo DM, Kang HS, Al-Osaimi AMS. Obesity and hepatocellular carcinoma. Gastroenterology 2004;127:897-103.
12. Adami HO, Chow WH, Nyren O, et al. Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 1996;89:317-8.
13. Wideroff L, Gridley G, Mellemkjaer L, et al. Cancer incidence in a population based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 1997;89:1360-5.
14. Lagiou P, Kuper H, Stuver SO, Tzonou A. Trichopoulos D, Adami HO. Role of diabetes mellitus in the etiology of hepatocellular carcinoma. J Natl Cancer Inst 2000;92:1096-9.
15. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut 2005;54:533-9.
16. Huo TI, Lee SD, Wu JC. Is diabetes a risk factor for hepatocellular carcinoma? Gastroenterology 2004;127:360-1.
17. El-Serag HB, Everhart JE. Reply to: Huo TI, Lee SD, Wu JC. Is diabetes a risk factor for hepatocellular carcinoma? Gastroenterology 2004;127:361-2.
18. Di Bisceglie AM. What every hepatologist should know about endocrinology: obesity, diabetes, and liver disease. Gastroenterology 2004;126:604-6.
19. Dombrowski F, Lehringer-Polzin M, Pfeifer U. Hyper-proliferative liver acini after intraportal islet transplantation in streptozotocin-induced diabetic rats. Lab Invest 1994;71:688-99.
20. Dombrowski F, Filsinger E, Bannasch P, Pfeifer U. Altered liver acini induced in diabetic rats by portal vein islet isografts resemble preneoplastic hepatic foci in their enzymic pattern. Am J Pathol 1996;148:1249-56.
21. Dombrowski F, Bannasch P, Pfeifer U. Hepatocellular neoplasms induced by low-number pancreatic islet transplants in streptozotocin diabetic rats. Am J Pathol 1997;150:1071-87.
22. Scharf JG, Ramadori G, Dombrowski F. Analysis of the IGF axis in preneoplastic hepatic foci and hepatocellular neoplasms developing after low-number pancreatic islet transplantation into the livers of streptozotocin diabetic rats. Lab Invest 2000;80:1399-411.
23. Evert M, Schneider-Stock R, Dombrowski F. Overexpression of fatty acid synthase in chemically and hormonally induced hepatocarcinogenesis of the rat. Lab Invest 2005;85:99-108.
24. Evert M, Sun JP, Pichler S, Slavova N, Schneider-Stock R, Dombrowski F. Insulin receptor, insulin receptor substrate-1, Raf-1, and Mek-1 during hormonal hepatocarcinogenesis by intrahepatic pancreatic islet transplantation in diabetic rats. Cancer Res 2004;64:8093-100.
25. Evert M, Schneider-Stock R, Dombrowski F. Apolipoprotein A-IV mRNA overexpression in early preneoplastic hepatic foci induced by low-number pancreatic islet transplants in streptozotocin-diabetic rats. Pathol Res Pract 2003;199:373-9.
26. Dombrowski F, Jost C, Manekeller S, Evert M. Cocarcinogenic effects of islet hormones and N-nitrosomorpholine in hepatocarcinogenesis after intrahepatic transplantation of pancreatic islets in streptozotocin-diabetic rats. Cancer Res 2005;65:7013-22.
27. Bannasch P. Pathogenesis of hepatocellular carcinoma: sequential cellular, molecular, and metabolic changes. Prog Liver Dis 1996;14:161-97.
28. Bannasch P, Klimek F, Mayer D. Early bioenergetic changes in hepatocarcinogenesis: preneoplastic phenotypes mimic responses to insulin and thyroid hormone. J Bioenerg Biomembr 1997;29:303-13.
29. Nehrbass D, Klimek F, Bannasch P. Overexpression of insulin receptor substrate-1 emerges early in hepatocarcinogenesis and elicits preneoplastic hepatic glycogenosis. Am J Pathol 1998;152:341-5.
30. Nehrbass D, Klimek F, Bannasch P, Mayer D. Insulin receptor substrate-1 is over-expressed in glycogenotic but not in amphophilic preneoplastic hepatic foci induced in rats by N-nitrosomorpholine and dehydroepiandrosterone. Cancer Lett 1999;140:75-9.
31. Bell RH, Jr., Hye WJ, Miyai K. Streptozotocin-induced liver tumors in the Syrian hamster. Carcinogenesis 1984;5:1235-8.
32. Kazumi T, Yoshino G, Fujii S, Baba S. Tumorigenic action of streptozotocin on the pancreas and kidney in male Wistar rats. Cancer Res 1978;38:2144-7.
33. Okawa H, Doi K. Neoplastic lesions in streptozotocin-treated rats. Exp Anim 1983;32:77-84.
34. Mordes JP, Desemone J, Rossini AA. The BB rat. Diabetes Metab 1987;3:725-50.
35. Malaisse WJ, Courtois P, Scott FW. Insulin-dependent diabetes and gut dysfunction: The BB rat model. Horm Metab Res 2004;36:585-94.
36. Ramanathan S, Poussier P. BB rat lyp mutation and type 1 diabetes. Immunol Rev 2001;184:161-71.
37. Hessner MJ, Wang X Meyer L, et al. Involvement of Eotaxin, eosinophils, and pancreatic predisposition in development of type 1 diabetes mellitus in the biobreeding rat. J Immunol 2004;173:6992-7002.
38. Mathieu C, Kuttler B, Waer M, Bouillon R, Hahn HJ. Spontaneous reestablishment of self-tolerance in BB/Pfd rats. Transplantation 1994;58:349-54.
39. Kuttler B, Mathieu C, Waer M, Hahn HJ, Bouillon R. Lack of disease recurrence in diabetic BB/Pfd rats after syngeneic islet transplantation. Autoimmunity 1993;15:107-12.
40. Richardson KC, Jarrett L, Finke EH. Embedding in epoxy resins for ultrathin sectioning in electron microscopy. Stain Technol 1960;35:313-25.
41. Benner U, Hacker HJ, Bannasch P. Electron microscopical demonstration of glucose-6-phosphatase in native cryostat sections fixed with glutaraldehyde through semipermeable membranes. Histochemistry 1979;65:41-7.
42. Schmitz F, Bresciani R, Hartmann H, Braulke T. Effect of insulin-like growth factor II on uptake of arylsulfatase A by cultured rat hepatocytes and Kupffer cells. J Hepatol 1995;22:356-63.
43. Meehan CJ, Fleming S, Smith W, Baird JD. Idiopathic megacolon in the BB rat. Int J Exp Pathol 1994;75:37-42.
44. Graham S, Courtois P, Malaisse WJ, Rozing J, Scott FW, Mowat AM. Enteropathy precedes type 1 diabetes in the BB rat. Gut 2004;53:1437-44.
45. Dombrowski F, Klingmüller D, Pfeifer U. Insulinomas derived from hyperplastic intra-hepatic islet transplants. Am J Pathol 1998;152:1025-38.
46. Jhappan C, Stahle C, Harkins NR, Fausto N, Smith GH, Merlino GT. TGF-α overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 1990;61:1137-46.
47. Lee GH, Merlino G, Fausto N. Development of liver tumors in transforming growth factor α transgenic mice. Cancer Res 1992;52:5162-70.
48. Hirshberg B, Mog S, Patterson N, Leconte J, Harlan DM. Histopathological study of intrahepatic islets transplanted in the nonhuman primate model using Edmonton protocol immunosuppression. J Clin Endocrinol Metab 2002;87:5424-9.
49. Sohn J, Siegelman ES, Osiason AW. Unusual patterns of hepatic steatosis caused by the local effect of insulin revealed on chemical shift MR imaging. AJR Am J Roentgenol 2001;176:471-4.
50. Bannasch P, Haertel T, Su Q. Significance of hepatic preneoplasia in risk identification and early detection of neoplasia. Toxicol Pathol 2003;31:134-9.
51. Su Q, Bannasch P. Relevance of hepatic preneoplasia for human hepatocarcinogenesis. Toxicol Pathol 2003;31:126-33.